NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on May 8, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date: Wednesday, May 8 th Time: 4:30 p.m.... Read More

NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor and industry conferences during the month of May: BTIG Obesity Health Forum, May 8, 2024. Management will participate in a virtual panel titled Obesity Management with Coaching, Eating, and Lifestyle Management moderated... Read More

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 15, 2024 to holders of record at the close of... Read More

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 23 rd Annual Needham Virtual Healthcare Conference taking place April 8-11, 2024. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors. About LifeMD, Inc. LifeMD is a leading provider of... Read More

Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period. Adjusted EPS of $0.15 per share compared with $0.02 in the year-ago period. Consolidated adjusted EBITDA of $5.5 million compared with $1.0 million in the year-ago period. Weight Management subscribers exceeded 22,000 as of year-end 2023, ahead of previous guidance. Telehealth subscribers... Read More

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2023 after the close of the U.S. financial markets on March 11, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date: Monday, March 11 th Time:... Read More

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced that management will be participating in three upcoming investor conferences and a webinar discussing GLP-1s. D.A. Davidson GLP-1 Webinar, February 26, 2024 . Justin Schreiber, Chief Executive Officer of LifeMD, will participate in a webinar with equity research analysts Gil Luria and Linda... Read More

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the 11 th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, being held February 13-14, 2024 at the Cliff Lodge in Snowbird, Utah. Management will hold one-on-one meetings throughout the conference. About LifeMD, Inc. LifeMD is a leading... Read More

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Conference, being held January 24-25, 2024. Management will participate in a virtual fireside chat on Wednesday, January 24 th at 10:00 a.m. Eastern time and will also hold one-on-one meetings throughout the conference. Investors... Read More

Revenue expected to be between $195 and $205 million, represents a 31% to 38% increase over the midpoint of 2023 guidance. Adjusted EBITDA expected to be between $18 and $22 million, representing an increase of 71% to 110% over the midpoint of 2023 guidance. Positive full-year free cash flow with estimated year-end 2023 cash exceeding $30 million. NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a... Read More

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc.™ (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on January 15, 2024, to holders of record at the close of... Read More

Collaboration will integrate LifeMD’s telehealth platform and GLP-1 offering for medically qualified patients with OPTAVIA Coach-guided, healthy lifestyle solution Medifast has invested $20 million, including a $10 million payment in support of the collaboration and a $10 million purchase of LifeMD common stock Conference call to discuss LifeMD and Medifast collaboration begins at 10:00 AM EST today NEW YORK, Dec. 13, 2023... Read More

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. ™ (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the RWJBarnabas Health Telehealth Symposium on Thursday, December 14 from 10:00 a.m. – 1:00 p.m. EST. The Symposium, which LifeMD is also sponsoring, will feature experts from RWJBarnabas Health and LifeMD discussing the increasingly important and complex role of... Read More

NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in two upcoming investor conferences and a panel discussion. Cantor Fitzgerald GLP-1 Panel: Payor vs. Provider Perspective, November 13, 2023 . Justin Schreiber, Chief Executive Officer of LifeMD, will participate in a panel discussion with Andrew... Read More

Revenue increased 23% year-over-year to $38.6 million with both telehealth and WorkSimpli achieving record revenues. Adjusted EPS of $0.08 per share compared with a loss of $0.03 in the year-ago period. Consolidated adjusted EBITDA increased to $2.8 million compared with a loss of $0.8 million in the year-ago period, and a 60% improvement versus the second quarter of 2023. Weight Management revenue more than quadrupled... Read More

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeMD (NASDAQ: LFMD), a leading direct-to-patient telehealth company, announced today it's been ranked 166 on the Deloitte Technology Fast 500 ™, a prestigious ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies in North America. LifeMD experienced remarkable growth during the ranking period (2019 to 2022),... Read More

NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2023 after the close of the U.S. financial markets on November 8, 2023 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date: Wednesday, November 8... Read More

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Particle Health , an intelligent data platform that aggregates and delivers actionable patient data and insights to healthcare companies, and LifeMD , Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the results of their joint study demonstrating that delivering actionable clinical insights can save healthcare providers valuable time and... Read More

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in two upcoming investor conferences in October. LD Micro Main Event XVI Conference, October 3-5, 2023 at the Luxe Sunset Boulevard Hotel in Los Angeles. Management will deliver a company presentation on Tuesday, October 3 rd at 3:30 p.m. Pacific... Read More

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on October 16, 2023, to holders of record at the close... Read More

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today launched a partnership with ASCEND Therapeutics US, LLC , a subsidiary of Besins Healthcare and a specialty pharmaceutical company concentrating on women's health, to provide integrated telehealth services to improve access to EstroGel ® 0.06% (estradiol gel). LifeMD’s telehealth services are... Read More

NEW YORK, Aug. 30, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) today announced that management will be participating in two upcoming investor conferences in September. H.C. Wainwright 25 th Annual Global Investment Conference, September 11-13, 2023 at the Lotte New York Palace Hotel in New York City. Management will deliver a company presentation on Wednesday, September 13 th at 3:30 p.m. Eastern Time and will be... Read More

Revenue grew 18% year-over-year to a record $35.9 million; telehealth net revenues increased 11% versus the first quarter of 2023. Achieved positive free cash flow, ahead of guidance. Adjusted EBITDA increased to $1.7 million in the second quarter 2023 from an adjusted EBITDA loss of $6.9 million in the year-ago period. Launched a comprehensive Weight Management program offering and onboarded over 5,000 new patient... Read More

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that management will be participating in Sidoti’s Micro-Cap Virtual Conference taking place August 16-17, 2023. Management will be presenting a corporate overview on August 17 at 10:00am Eastern time and will be hosting one-on-one meetings with investors. The presentation will be webcast... Read More

NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three months ended June 30, 2023 after the close of the U.S. financial markets on August 9, 2023 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date: Wednesday, August 9 th Time: 4:30 p.m.... Read More

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 17, 2023, to holders of record at the close of... Read More

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the formal launch of its GLP-1 weight management program following a successful pilot earlier this year. The formal launch of LifeMD’s weight management program coincides with bespoke... Read More

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, today announced the appointment of William (Will) J. Febbo, Chief Executive Officer and Director of OptimizeRx Corporation (Nasdaq: OPRX) to its Board of Directors. OptimizeRx is a leading provider of digital point-of-care technology solutions that help patients start and stay on therapy. “We are... Read More

Record first quarter 2023 consolidated revenue of $33.1 million, up 14% from the same year-ago period. Record Adjusted EPS of $0.06 per share, up 126% versus the prior year. Record Adjusted EBITDA of $2.0 million, up 126% versus the prior year. Executed debt financing transaction with Avenue Capital, providing up to $40 million of total capital and strengthening LifeMD’s long-term capital position. Re-affirm Full Year 2023... Read More

NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced that it has entered into an agreement to be the exclusive telehealth provider for HealthWarehouse.com, Inc. (OTC: HEWA). The partnership between the two companies will enable HealthWarehouse.com to offer virtual treatment to over one million existing patients and make available... Read More

NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the first quarter ended March 31, 2023 before the market open on Friday, May 12, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:30am Eastern Time.... Read More

NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced the launch of new membership plans that enable immediate access to best-in-class virtual care. LifeMD’s new plans, powered by innovative features and enhancements to its proprietary app, expand care and provide patients with the most flexibility when seeking virtual treatment.... Read More

NEW YORK, March 28, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 17, 2023, to holders of record at the close of... Read More

Achieved consolidated Adjusted EBITDA profitability for first-time in LifeMD history Full Year 2022 consolidated revenue of $119.0 million, up 28% from the same year-ago period. Fourth quarter 2022 consolidated revenue of $28.1 million up 3% from the same year-ago period. This figure was impacted by a $2.9 million deferral of telehealth shipments. Adjusted EPS of $0.02, 107% improvement versus the prior year. Subsequent to... Read More

NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that the Company closed on a new senior secured credit facility with Avenue Capital. The credit agreement, which matures on October 1, 2026, provides up to $40 million in total term loan capital including a first tranche of $15 million funded at closing, a second tranche of $5 million of... Read More

NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Wednesday, March 22, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at... Read More

NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Dr. Joan LaRovere to its Board of Directors. With Dr. LaRovere’s appointment, LifeMD’s Board will comprise nine directors, seven of whom are independent. “We are pleased to welcome Dr. LaRovere to the LifeMD Board,” said Justin Schreiber, Chairman and Chief Executive... Read More

NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Jessica Friedeman as Chief Marketing Officer. Friedeman succeeds Stefan Galluppi, who continues as LifeMD’s Chief Innovation Officer. Friedeman brings nearly twenty years’ experience engaging and retaining patients, with a proven track record of increasing efficiency and... Read More

NEW YORK, Dec. 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on January 17, 2023, to holders of record at the close of... Read More

Fourteenth consecutive quarter of record consolidated revenue. Third quarter 2022 consolidated revenue of $31.4 million up 26% from the same year ago period. Adjusted EPS of $(0.03), 91% improvement versus the prior year, 86% sequentially versus prior quarter. Remain on track to achieve consolidated Adjusted EBITDA profitability in fourth quarter 2022. Consolidated Adjusted EBITDA loss for the third quarter reduced to... Read More